nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—F10—Extrinsic Pathway—F7—type 2 diabetes mellitus	0.0219	0.077	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—LAMA1—type 2 diabetes mellitus	0.0194	0.0682	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Common Pathway—THBD—type 2 diabetes mellitus	0.0173	0.0606	CbGpPWpGaD
Fondaparinux sodium—F10—Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus—F7—type 2 diabetes mellitus	0.0151	0.0528	CbGpPWpGaD
Fondaparinux sodium—F10—Removal of aminoterminal propeptides from gamma-carboxylated proteins—F7—type 2 diabetes mellitus	0.0137	0.0481	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation of protein precursors—F7—type 2 diabetes mellitus	0.0137	0.0481	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F7—type 2 diabetes mellitus	0.0117	0.041	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—THBD—type 2 diabetes mellitus	0.00993	0.0348	CbGpPWpGaD
Fondaparinux sodium—F10—Common Pathway—THBD—type 2 diabetes mellitus	0.00976	0.0343	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F7—type 2 diabetes mellitus	0.008	0.0281	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFBR2—type 2 diabetes mellitus	0.00736	0.0258	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—F7—type 2 diabetes mellitus	0.0067	0.0235	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—THBD—type 2 diabetes mellitus	0.00669	0.0235	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLAT—type 2 diabetes mellitus	0.00597	0.021	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—THBD—type 2 diabetes mellitus	0.00561	0.0197	CbGpPWpGaD
Fondaparinux sodium—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F7—type 2 diabetes mellitus	0.00553	0.0194	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F7—type 2 diabetes mellitus	0.00539	0.0189	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAT—type 2 diabetes mellitus	0.0048	0.0169	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAT—type 2 diabetes mellitus	0.00479	0.0168	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F7—type 2 diabetes mellitus	0.00452	0.0159	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—THBD—type 2 diabetes mellitus	0.00378	0.0133	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—C3—type 2 diabetes mellitus	0.0031	0.0109	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—C3—type 2 diabetes mellitus	0.0031	0.0109	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—SRC—type 2 diabetes mellitus	0.00308	0.0108	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F7—type 2 diabetes mellitus	0.00304	0.0107	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—type 2 diabetes mellitus	0.003	0.0105	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—SERPINE1—type 2 diabetes mellitus	0.00282	0.0099	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFB1—type 2 diabetes mellitus	0.00276	0.00968	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAT—type 2 diabetes mellitus	0.00271	0.00952	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ICAM1—type 2 diabetes mellitus	0.00271	0.0095	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GRB14—type 2 diabetes mellitus	0.00245	0.00861	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—SERPINE1—type 2 diabetes mellitus	0.00227	0.00796	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—ADAMTS9—type 2 diabetes mellitus	0.00185	0.0065	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—C3—type 2 diabetes mellitus	0.00175	0.00615	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PCSK2—type 2 diabetes mellitus	0.00153	0.00537	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ATP2A3—type 2 diabetes mellitus	0.00141	0.00494	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GRB14—type 2 diabetes mellitus	0.00139	0.00486	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—WFS1—type 2 diabetes mellitus	0.00136	0.00479	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—ST6GAL1—type 2 diabetes mellitus	0.00136	0.00477	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINE1—type 2 diabetes mellitus	0.00128	0.0045	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—THBD—type 2 diabetes mellitus	0.0012	0.0042	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—liver—type 2 diabetes mellitus	0.00112	0.531	CbGeAlD
Fondaparinux sodium—SERPINC1—Hemostasis—ATP2A2—type 2 diabetes mellitus	0.00101	0.00355	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TRPC6—type 2 diabetes mellitus	0.000982	0.00345	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—F7—type 2 diabetes mellitus	0.000966	0.00339	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—F7—type 2 diabetes mellitus	0.000905	0.00317	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	0.000879	0.00308	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ADRA2A—type 2 diabetes mellitus	0.000864	0.00303	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAT—type 2 diabetes mellitus	0.000861	0.00302	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TIMP1—type 2 diabetes mellitus	0.000861	0.00302	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS1—type 2 diabetes mellitus	0.000809	0.00284	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ATP2A3—type 2 diabetes mellitus	0.000796	0.00279	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PTPN1—type 2 diabetes mellitus	0.000787	0.00276	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RASGRP1—type 2 diabetes mellitus	0.000774	0.00272	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—DPP4—type 2 diabetes mellitus	0.000717	0.00251	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	0.000717	0.00251	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SOD1—type 2 diabetes mellitus	0.000702	0.00246	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GIP—type 2 diabetes mellitus	0.00069	0.00242	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GNB3—type 2 diabetes mellitus	0.000679	0.00238	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—THBD—type 2 diabetes mellitus	0.000677	0.00238	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF2—type 2 diabetes mellitus	0.000666	0.00234	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	0.000666	0.00234	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—APOB—type 2 diabetes mellitus	0.000647	0.00227	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	0.000645	0.00226	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD36—type 2 diabetes mellitus	0.000587	0.00206	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PPP2CA—type 2 diabetes mellitus	0.00058	0.00203	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ATP2A2—type 2 diabetes mellitus	0.000572	0.00201	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TRPC6—type 2 diabetes mellitus	0.000555	0.00195	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F7—type 2 diabetes mellitus	0.000546	0.00191	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MMP1—type 2 diabetes mellitus	0.000535	0.00188	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CALM1—type 2 diabetes mellitus	0.00052	0.00182	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—APOA1—type 2 diabetes mellitus	0.000512	0.0018	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ADRA2A—type 2 diabetes mellitus	0.000488	0.00171	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKCB—type 2 diabetes mellitus	0.000488	0.00171	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TIMP1—type 2 diabetes mellitus	0.000486	0.00171	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAT—type 2 diabetes mellitus	0.000486	0.00171	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS2—type 2 diabetes mellitus	0.000483	0.00169	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000478	0.00168	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS1—type 2 diabetes mellitus	0.000457	0.0016	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PTPN1—type 2 diabetes mellitus	0.000445	0.00156	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RASGRP1—type 2 diabetes mellitus	0.000438	0.00154	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000429	0.00151	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF1—type 2 diabetes mellitus	0.000428	0.0015	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT2—type 2 diabetes mellitus	0.000428	0.0015	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.000418	0.00147	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINE1—type 2 diabetes mellitus	0.000406	0.00143	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ALB—type 2 diabetes mellitus	0.000406	0.00142	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SOD1—type 2 diabetes mellitus	0.000396	0.00139	CbGpPWpGaD
Fondaparinux sodium—F10—cardiovascular system—type 2 diabetes mellitus	0.000393	0.187	CbGeAlD
Fondaparinux sodium—Pain—Gliclazide—type 2 diabetes mellitus	0.00039	0.000547	CcSEcCtD
Fondaparinux sodium—Constipation—Gliclazide—type 2 diabetes mellitus	0.00039	0.000547	CcSEcCtD
Fondaparinux sodium—Rash—Glimepiride—type 2 diabetes mellitus	0.000388	0.000545	CcSEcCtD
Fondaparinux sodium—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000388	0.000544	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3R1—type 2 diabetes mellitus	0.000388	0.00136	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS3—type 2 diabetes mellitus	0.000388	0.00136	CbGpPWpGaD
Fondaparinux sodium—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000388	0.000544	CcSEcCtD
Fondaparinux sodium—Rash—Sitagliptin—type 2 diabetes mellitus	0.000387	0.000543	CcSEcCtD
Fondaparinux sodium—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000387	0.000542	CcSEcCtD
Fondaparinux sodium—Headache—Glimepiride—type 2 diabetes mellitus	0.000386	0.000541	CcSEcCtD
Fondaparinux sodium—Cough—Irbesartan—type 2 diabetes mellitus	0.000385	0.00054	CcSEcCtD
Fondaparinux sodium—Headache—Sitagliptin—type 2 diabetes mellitus	0.000385	0.000539	CcSEcCtD
Fondaparinux sodium—Anaemia—Losartan—type 2 diabetes mellitus	0.000384	0.000538	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—GNB3—type 2 diabetes mellitus	0.000383	0.00135	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000383	0.00134	CbGpPWpGaD
Fondaparinux sodium—Oedema—Metformin—type 2 diabetes mellitus	0.000382	0.000535	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00038	0.000533	CcSEcCtD
Fondaparinux sodium—Flushing—Ramipril—type 2 diabetes mellitus	0.00038	0.000532	CcSEcCtD
Fondaparinux sodium—Angioedema—Losartan—type 2 diabetes mellitus	0.000379	0.000532	CcSEcCtD
Fondaparinux sodium—Infection—Metformin—type 2 diabetes mellitus	0.000379	0.000532	CcSEcCtD
Fondaparinux sodium—Insomnia—Valsartan—type 2 diabetes mellitus	0.000379	0.000532	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—IGF2—type 2 diabetes mellitus	0.000377	0.00132	CbGpPWpGaD
Fondaparinux sodium—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000376	0.000528	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000376	0.000527	CcSEcCtD
Fondaparinux sodium—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000376	0.000527	CcSEcCtD
Fondaparinux sodium—Shock—Metformin—type 2 diabetes mellitus	0.000375	0.000527	CcSEcCtD
Fondaparinux sodium—Insomnia—Orlistat—type 2 diabetes mellitus	0.000374	0.000525	CcSEcCtD
Fondaparinux sodium—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000374	0.000525	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000374	0.000525	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000374	0.000525	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000374	0.000524	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000374	0.000524	CcSEcCtD
Fondaparinux sodium—Vertigo—Losartan—type 2 diabetes mellitus	0.000373	0.000523	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000373	0.000523	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000373	0.000523	CcSEcCtD
Fondaparinux sodium—Somnolence—Valsartan—type 2 diabetes mellitus	0.000372	0.000522	CcSEcCtD
Fondaparinux sodium—Syncope—Losartan—type 2 diabetes mellitus	0.000372	0.000522	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000372	0.000521	CcSEcCtD
Fondaparinux sodium—Skin disorder—Metformin—type 2 diabetes mellitus	0.000371	0.00052	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000371	0.0013	CbGpPWpGaD
Fondaparinux sodium—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000369	0.000518	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000369	0.000517	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000369	0.000517	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000369	0.000517	CcSEcCtD
Fondaparinux sodium—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000367	0.000515	CcSEcCtD
Fondaparinux sodium—Palpitations—Losartan—type 2 diabetes mellitus	0.000367	0.000515	CcSEcCtD
Fondaparinux sodium—Nausea—Glimepiride—type 2 diabetes mellitus	0.000366	0.000513	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—APOB—type 2 diabetes mellitus	0.000366	0.00128	CbGpPWpGaD
Fondaparinux sodium—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000365	0.000512	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000365	0.000512	CcSEcCtD
Fondaparinux sodium—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000365	0.000511	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000364	0.000511	CcSEcCtD
Fondaparinux sodium—Asthenia—Glyburide—type 2 diabetes mellitus	0.000364	0.000511	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000364	0.000511	CcSEcCtD
Fondaparinux sodium—Anorexia—Metformin—type 2 diabetes mellitus	0.000364	0.00051	CcSEcCtD
Fondaparinux sodium—Cough—Losartan—type 2 diabetes mellitus	0.000362	0.000508	CcSEcCtD
Fondaparinux sodium—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000362	0.000508	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000362	0.000507	CcSEcCtD
Fondaparinux sodium—Fatigue—Valsartan—type 2 diabetes mellitus	0.000361	0.000507	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000361	0.000506	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000361	0.000506	CcSEcCtD
Fondaparinux sodium—Oedema—Irbesartan—type 2 diabetes mellitus	0.00036	0.000505	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00036	0.000505	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00036	0.000505	CcSEcCtD
Fondaparinux sodium—Pruritus—Glyburide—type 2 diabetes mellitus	0.000359	0.000504	CcSEcCtD
Fondaparinux sodium—Constipation—Valsartan—type 2 diabetes mellitus	0.000358	0.000503	CcSEcCtD
Fondaparinux sodium—Infection—Irbesartan—type 2 diabetes mellitus	0.000358	0.000502	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000357	0.000501	CcSEcCtD
Fondaparinux sodium—Fatigue—Orlistat—type 2 diabetes mellitus	0.000357	0.000501	CcSEcCtD
Fondaparinux sodium—Hypotension—Metformin—type 2 diabetes mellitus	0.000357	0.0005	CcSEcCtD
Fondaparinux sodium—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000356	0.000499	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000356	0.00125	CbGpPWpGaD
Fondaparinux sodium—Shock—Irbesartan—type 2 diabetes mellitus	0.000354	0.000497	CcSEcCtD
Fondaparinux sodium—Pain—Orlistat—type 2 diabetes mellitus	0.000354	0.000497	CcSEcCtD
Fondaparinux sodium—Chest pain—Losartan—type 2 diabetes mellitus	0.000353	0.000496	CcSEcCtD
Fondaparinux sodium—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000353	0.000495	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000353	0.000495	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000353	0.000495	CcSEcCtD
Fondaparinux sodium—Anxiety—Losartan—type 2 diabetes mellitus	0.000352	0.000494	CcSEcCtD
Fondaparinux sodium—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000351	0.000493	CcSEcCtD
Fondaparinux sodium—Rash—Bromocriptine—type 2 diabetes mellitus	0.00035	0.000491	CcSEcCtD
Fondaparinux sodium—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00035	0.000491	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.00035	0.00123	CbGpPWpGaD
Fondaparinux sodium—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00035	0.000491	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000349	0.000489	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000348	0.000488	CcSEcCtD
Fondaparinux sodium—Headache—Bromocriptine—type 2 diabetes mellitus	0.000348	0.000488	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000347	0.000487	CcSEcCtD
Fondaparinux sodium—F10—adipose tissue—type 2 diabetes mellitus	0.000347	0.165	CbGeAlD
Fondaparinux sodium—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000343	0.000481	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000343	0.000481	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000343	0.000481	CcSEcCtD
Fondaparinux sodium—Confusional state—Losartan—type 2 diabetes mellitus	0.000342	0.000479	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000341	0.000479	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00034	0.000477	CcSEcCtD
Fondaparinux sodium—Somnolence—Metformin—type 2 diabetes mellitus	0.000339	0.000476	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000339	0.000475	CcSEcCtD
Fondaparinux sodium—Oedema—Losartan—type 2 diabetes mellitus	0.000339	0.000475	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000339	0.000475	CcSEcCtD
Fondaparinux sodium—Infection—Losartan—type 2 diabetes mellitus	0.000337	0.000472	CcSEcCtD
Fondaparinux sodium—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000336	0.000472	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000336	0.000471	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000336	0.000471	CcSEcCtD
Fondaparinux sodium—Shock—Losartan—type 2 diabetes mellitus	0.000333	0.000468	CcSEcCtD
Fondaparinux sodium—Urticaria—Valsartan—type 2 diabetes mellitus	0.000333	0.000467	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000332	0.000466	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000332	0.000465	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000332	0.000465	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—CD36—type 2 diabetes mellitus	0.000332	0.00116	CbGpPWpGaD
Fondaparinux sodium—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000331	0.000465	CcSEcCtD
Fondaparinux sodium—Tachycardia—Losartan—type 2 diabetes mellitus	0.000331	0.000464	CcSEcCtD
Fondaparinux sodium—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00033	0.000463	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000329	0.000462	CcSEcCtD
Fondaparinux sodium—Fatigue—Metformin—type 2 diabetes mellitus	0.000329	0.000461	CcSEcCtD
Fondaparinux sodium—Urticaria—Orlistat—type 2 diabetes mellitus	0.000329	0.000461	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000328	0.000459	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PPP2CA—type 2 diabetes mellitus	0.000327	0.00115	CbGpPWpGaD
Fondaparinux sodium—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000327	0.000459	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000327	0.000459	CcSEcCtD
Fondaparinux sodium—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000327	0.000459	CcSEcCtD
Fondaparinux sodium—Constipation—Metformin—type 2 diabetes mellitus	0.000326	0.000458	CcSEcCtD
Fondaparinux sodium—Angioedema—Ramipril—type 2 diabetes mellitus	0.000325	0.000456	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000323	0.000454	CcSEcCtD
Fondaparinux sodium—Anorexia—Losartan—type 2 diabetes mellitus	0.000323	0.000453	CcSEcCtD
Fondaparinux sodium—Vomiting—Glyburide—type 2 diabetes mellitus	0.000323	0.000453	CcSEcCtD
Fondaparinux sodium—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000323	0.000453	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000321	0.00045	CcSEcCtD
Fondaparinux sodium—Rash—Glyburide—type 2 diabetes mellitus	0.00032	0.000449	CcSEcCtD
Fondaparinux sodium—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00032	0.000449	CcSEcCtD
Fondaparinux sodium—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00032	0.000449	CcSEcCtD
Fondaparinux sodium—Vertigo—Ramipril—type 2 diabetes mellitus	0.00032	0.000449	CcSEcCtD
Fondaparinux sodium—Syncope—Ramipril—type 2 diabetes mellitus	0.000319	0.000448	CcSEcCtD
Fondaparinux sodium—Headache—Glyburide—type 2 diabetes mellitus	0.000318	0.000446	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000317	0.000445	CcSEcCtD
Fondaparinux sodium—Hypotension—Losartan—type 2 diabetes mellitus	0.000317	0.000444	CcSEcCtD
Fondaparinux sodium—Palpitations—Ramipril—type 2 diabetes mellitus	0.000315	0.000441	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000314	0.000441	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000313	0.000439	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000313	0.000439	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000312	0.000438	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000312	0.000438	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000311	0.000436	CcSEcCtD
Fondaparinux sodium—Cough—Ramipril—type 2 diabetes mellitus	0.000311	0.000436	CcSEcCtD
Fondaparinux sodium—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00031	0.000435	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000309	0.000433	CcSEcCtD
Fondaparinux sodium—Convulsion—Ramipril—type 2 diabetes mellitus	0.000308	0.000433	CcSEcCtD
Fondaparinux sodium—Pain—Irbesartan—type 2 diabetes mellitus	0.000308	0.000432	CcSEcCtD
Fondaparinux sodium—Constipation—Irbesartan—type 2 diabetes mellitus	0.000308	0.000432	CcSEcCtD
Fondaparinux sodium—Insomnia—Losartan—type 2 diabetes mellitus	0.000306	0.00043	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000305	0.000428	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000304	0.000427	CcSEcCtD
Fondaparinux sodium—Urticaria—Metformin—type 2 diabetes mellitus	0.000303	0.000425	CcSEcCtD
Fondaparinux sodium—Chest pain—Ramipril—type 2 diabetes mellitus	0.000303	0.000425	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—MMP1—type 2 diabetes mellitus	0.000302	0.00106	CbGpPWpGaD
Fondaparinux sodium—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000302	0.000424	CcSEcCtD
Fondaparinux sodium—Anxiety—Ramipril—type 2 diabetes mellitus	0.000302	0.000424	CcSEcCtD
Fondaparinux sodium—Nausea—Glyburide—type 2 diabetes mellitus	0.000302	0.000423	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000302	0.000423	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000302	0.00106	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000302	0.000423	CcSEcCtD
Fondaparinux sodium—Somnolence—Losartan—type 2 diabetes mellitus	0.000301	0.000423	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000301	0.000422	CcSEcCtD
Fondaparinux sodium—Asthenia—Valsartan—type 2 diabetes mellitus	0.000301	0.000422	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000298	0.000418	CcSEcCtD
Fondaparinux sodium—Asthenia—Orlistat—type 2 diabetes mellitus	0.000297	0.000417	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000297	0.000416	CcSEcCtD
Fondaparinux sodium—Pruritus—Valsartan—type 2 diabetes mellitus	0.000296	0.000416	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000296	0.00104	CbGpPWpGaD
Fondaparinux sodium—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000295	0.000413	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000294	0.000413	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—CALM1—type 2 diabetes mellitus	0.000294	0.00103	CbGpPWpGaD
Fondaparinux sodium—Confusional state—Ramipril—type 2 diabetes mellitus	0.000293	0.000411	CcSEcCtD
Fondaparinux sodium—Pruritus—Orlistat—type 2 diabetes mellitus	0.000293	0.000411	CcSEcCtD
Fondaparinux sodium—Fatigue—Losartan—type 2 diabetes mellitus	0.000292	0.00041	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000291	0.000408	CcSEcCtD
Fondaparinux sodium—Oedema—Ramipril—type 2 diabetes mellitus	0.000291	0.000408	CcSEcCtD
Fondaparinux sodium—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00029	0.000407	CcSEcCtD
Fondaparinux sodium—Pain—Losartan—type 2 diabetes mellitus	0.00029	0.000406	CcSEcCtD
Fondaparinux sodium—Constipation—Losartan—type 2 diabetes mellitus	0.00029	0.000406	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—APOA1—type 2 diabetes mellitus	0.000289	0.00101	CbGpPWpGaD
Fondaparinux sodium—Rash—Gliclazide—type 2 diabetes mellitus	0.000288	0.000403	CcSEcCtD
Fondaparinux sodium—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000287	0.000403	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—SRC—type 2 diabetes mellitus	0.000287	0.00101	CbGpPWpGaD
Fondaparinux sodium—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000287	0.000402	CcSEcCtD
Fondaparinux sodium—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000286	0.000401	CcSEcCtD
Fondaparinux sodium—Shock—Ramipril—type 2 diabetes mellitus	0.000286	0.000401	CcSEcCtD
Fondaparinux sodium—Headache—Gliclazide—type 2 diabetes mellitus	0.000286	0.000401	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000285	0.0004	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000285	0.000399	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000285	0.000399	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000284	0.000399	CcSEcCtD
Fondaparinux sodium—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000284	0.000398	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000283	0.000397	CcSEcCtD
Fondaparinux sodium—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000282	0.000396	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000281	0.000394	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—type 2 diabetes mellitus	0.000279	0.000981	CbGpPWpGaD
Fondaparinux sodium—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000279	0.000392	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000277	0.000389	CcSEcCtD
Fondaparinux sodium—Dizziness—Valsartan—type 2 diabetes mellitus	0.000277	0.000389	CcSEcCtD
Fondaparinux sodium—Anorexia—Ramipril—type 2 diabetes mellitus	0.000277	0.000388	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PRKCB—type 2 diabetes mellitus	0.000276	0.000968	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Orlistat—type 2 diabetes mellitus	0.000274	0.000384	CcSEcCtD
Fondaparinux sodium—Asthenia—Metformin—type 2 diabetes mellitus	0.000274	0.000384	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—NOS2—type 2 diabetes mellitus	0.000273	0.000957	CbGpPWpGaD
Fondaparinux sodium—Hypotension—Ramipril—type 2 diabetes mellitus	0.000272	0.000381	CcSEcCtD
Fondaparinux sodium—Nausea—Gliclazide—type 2 diabetes mellitus	0.000271	0.00038	CcSEcCtD
Fondaparinux sodium—Pruritus—Metformin—type 2 diabetes mellitus	0.00027	0.000379	CcSEcCtD
Fondaparinux sodium—Urticaria—Losartan—type 2 diabetes mellitus	0.000269	0.000378	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000268	0.000376	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000268	0.000376	CcSEcCtD
Fondaparinux sodium—Vomiting—Valsartan—type 2 diabetes mellitus	0.000266	0.000374	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000265	0.000372	CcSEcCtD
Fondaparinux sodium—Rash—Valsartan—type 2 diabetes mellitus	0.000264	0.000371	CcSEcCtD
Fondaparinux sodium—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000264	0.00037	CcSEcCtD
Fondaparinux sodium—Vomiting—Orlistat—type 2 diabetes mellitus	0.000263	0.000369	CcSEcCtD
Fondaparinux sodium—Insomnia—Ramipril—type 2 diabetes mellitus	0.000263	0.000369	CcSEcCtD
Fondaparinux sodium—Headache—Valsartan—type 2 diabetes mellitus	0.000262	0.000368	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000261	0.000366	CcSEcCtD
Fondaparinux sodium—Rash—Orlistat—type 2 diabetes mellitus	0.000261	0.000366	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000261	0.000366	CcSEcCtD
Fondaparinux sodium—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000261	0.000366	CcSEcCtD
Fondaparinux sodium—Headache—Orlistat—type 2 diabetes mellitus	0.000259	0.000364	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000259	0.000363	CcSEcCtD
Fondaparinux sodium—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000258	0.000362	CcSEcCtD
Fondaparinux sodium—Somnolence—Ramipril—type 2 diabetes mellitus	0.000258	0.000362	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB1—type 2 diabetes mellitus	0.000257	0.0009	CbGpPWpGaD
Fondaparinux sodium—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000256	0.000359	CcSEcCtD
Fondaparinux sodium—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000255	0.000357	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000253	0.000354	CcSEcCtD
Fondaparinux sodium—Dizziness—Metformin—type 2 diabetes mellitus	0.000252	0.000354	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000251	0.000352	CcSEcCtD
Fondaparinux sodium—Fatigue—Ramipril—type 2 diabetes mellitus	0.000251	0.000351	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00025	0.00035	CcSEcCtD
Fondaparinux sodium—Nausea—Valsartan—type 2 diabetes mellitus	0.000249	0.000349	CcSEcCtD
Fondaparinux sodium—Constipation—Ramipril—type 2 diabetes mellitus	0.000248	0.000349	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000246	0.000346	CcSEcCtD
Fondaparinux sodium—Nausea—Orlistat—type 2 diabetes mellitus	0.000246	0.000345	CcSEcCtD
Fondaparinux sodium—F10—liver—type 2 diabetes mellitus	0.000243	0.116	CbGeAlD
Fondaparinux sodium—Asthenia—Losartan—type 2 diabetes mellitus	0.000243	0.000341	CcSEcCtD
Fondaparinux sodium—Vomiting—Metformin—type 2 diabetes mellitus	0.000243	0.00034	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—IGF1—type 2 diabetes mellitus	0.000242	0.000848	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT2—type 2 diabetes mellitus	0.000242	0.000848	CbGpPWpGaD
Fondaparinux sodium—Rash—Metformin—type 2 diabetes mellitus	0.000241	0.000337	CcSEcCtD
Fondaparinux sodium—Dermatitis—Metformin—type 2 diabetes mellitus	0.00024	0.000337	CcSEcCtD
Fondaparinux sodium—Pruritus—Losartan—type 2 diabetes mellitus	0.00024	0.000336	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000239	0.000336	CcSEcCtD
Fondaparinux sodium—Headache—Metformin—type 2 diabetes mellitus	0.000239	0.000335	CcSEcCtD
Fondaparinux sodium—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000238	0.000334	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000238	0.000835	CbGpPWpGaD
Fondaparinux sodium—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000238	0.000333	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000235	0.000824	CbGpPWpGaD
Fondaparinux sodium—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000232	0.000325	CcSEcCtD
Fondaparinux sodium—Urticaria—Ramipril—type 2 diabetes mellitus	0.000231	0.000324	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.00023	0.000808	CbGpPWpGaD
Fondaparinux sodium—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00023	0.000322	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00023	0.000322	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—SERPINE1—type 2 diabetes mellitus	0.00023	0.000806	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ALB—type 2 diabetes mellitus	0.000229	0.000804	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000229	0.000321	CcSEcCtD
Fondaparinux sodium—Rash—Irbesartan—type 2 diabetes mellitus	0.000227	0.000318	CcSEcCtD
Fondaparinux sodium—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000227	0.000318	CcSEcCtD
Fondaparinux sodium—Nausea—Metformin—type 2 diabetes mellitus	0.000227	0.000318	CcSEcCtD
Fondaparinux sodium—Headache—Irbesartan—type 2 diabetes mellitus	0.000226	0.000316	CcSEcCtD
Fondaparinux sodium—Dizziness—Losartan—type 2 diabetes mellitus	0.000224	0.000314	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—NOS3—type 2 diabetes mellitus	0.000219	0.000769	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3R1—type 2 diabetes mellitus	0.000219	0.000769	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Losartan—type 2 diabetes mellitus	0.000215	0.000302	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000214	0.0003	CcSEcCtD
Fondaparinux sodium—Nausea—Irbesartan—type 2 diabetes mellitus	0.000214	0.0003	CcSEcCtD
Fondaparinux sodium—Rash—Losartan—type 2 diabetes mellitus	0.000214	0.0003	CcSEcCtD
Fondaparinux sodium—Dermatitis—Losartan—type 2 diabetes mellitus	0.000213	0.000299	CcSEcCtD
Fondaparinux sodium—Headache—Losartan—type 2 diabetes mellitus	0.000212	0.000298	CcSEcCtD
Fondaparinux sodium—Asthenia—Ramipril—type 2 diabetes mellitus	0.000208	0.000292	CcSEcCtD
Fondaparinux sodium—Pruritus—Ramipril—type 2 diabetes mellitus	0.000206	0.000288	CcSEcCtD
Fondaparinux sodium—Nausea—Losartan—type 2 diabetes mellitus	0.000201	0.000282	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000199	0.000279	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—INS—type 2 diabetes mellitus	0.000197	0.00069	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CCL2—type 2 diabetes mellitus	0.000193	0.000679	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Ramipril—type 2 diabetes mellitus	0.000192	0.00027	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—IGF1—type 2 diabetes mellitus	0.00019	0.000667	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Ramipril—type 2 diabetes mellitus	0.000185	0.000259	CcSEcCtD
Fondaparinux sodium—Rash—Ramipril—type 2 diabetes mellitus	0.000183	0.000257	CcSEcCtD
Fondaparinux sodium—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000183	0.000257	CcSEcCtD
Fondaparinux sodium—Headache—Ramipril—type 2 diabetes mellitus	0.000182	0.000255	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—type 2 diabetes mellitus	0.000178	0.000626	CbGpPWpGaD
Fondaparinux sodium—Nausea—Ramipril—type 2 diabetes mellitus	0.000173	0.000242	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—SRC—type 2 diabetes mellitus	0.000162	0.000569	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFA—type 2 diabetes mellitus	0.000158	0.000554	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TGFB1—type 2 diabetes mellitus	0.000145	0.000509	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT1—type 2 diabetes mellitus	0.000101	0.000354	CbGpPWpGaD
